Hypertension-related disease in African Americans: Factors underlying disparities in illness and its outcome

Postgraduate Medicine

Volumn 112, Issue 4, 2002, Pages

  Sowers, James R ^a   Ferdinand, Keith C ^a   Bakris, George L ^a   Douglas, Janice G ^a  

^a SUNY DOWNSTATE MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CARDIOVASCULAR DISEASE; CEREBROVASCULAR DISEASE; COMORBIDITY; CONFERENCE PAPER; CORRELATION ANALYSIS; DIABETES MELLITUS; DISEASE COURSE; DYSLIPIDEMIA; ETHNIC DIFFERENCE; ETHNIC GROUP; GENETIC PREDISPOSITION; HIGH RISK POPULATION; HUMAN; HYPERTENSION; KIDNEY DISEASE; PATHOGENESIS; PREVALENCE; SOCIAL ASPECT; STROKE;

EID: 0036797118     PISSN: 00325481     EISSN: None     Source Type: Journal    
DOI: 10.3810/pgm.2002.10.1331     Document Type: Conference Paper

References (29)

1. American Heart Association. 2000 heart and stroke statistical update. Dallas: American Heart Association, 2001
2. Sowers JR, Epstein M, Frohlich E. Diabetes, hypertension, and cardiovascular disease: an update. Hypertension 2001;37(4):1053-9
3. US Census Bureau. Profile of general demographic characteristics: 2000 census of population and housing. Washington, DC: US Census Bureau, 2000
4. Hyman DJ, Pavlik VN. Characteristics of patients with uncontrolled hypertension in the United States. N Engl J Med 2001;345(7):479-86
5. Geronimus AT, Andersen HF, Bound J. Differences in hypertension prevalence among US black and white women of childbearing age. Public Health Rep 1991;106(4):393-9
6. Lackland DT, Egan BM, Fan ZJ, et al. Low birth weight contributes to the excess prevalence of end-stage renal disease in African Americans. J Clin Hypertens (Greenwich) 2001;3(1):29-31
7. Berenson GS, Voors AW, Webber LS, et al. Racial differences of parameters associated with blood pressure levels in children - the Bogalusa Heart Study. Metabolism 1979;28(12):1218-28
8. Young-Hyman D, Schlundt DG, Herman L, et al. Evaluation of the insulin resistance syndrome in 5- to 10-year-old overweight/obese African-American children. Diabetes Care 2001;24(8):1359-64
9. Apedo MT, Sowers JR, Banerji MA. Cardiovascular disease in adolescents with type 2 diabetes mellitus. J Pediatr Endocrinol Metab 2002;15(Suppl 1):519-23
10. McFarlane SI, Banerji MA, Sowers JR. Insulin resistance and cardiovascular disease. J Clin Endocrinol Metab 2001;86(2):713-8
11. Rahman M, Douglas JG, Wright JT Jr. Pathophysiology and treatment implications of hypertension in the African-American population. Endocrinol Metab Clin North Am 1997;26(1):125-44
12. Cooper R, Rotimi C. Hypertension in blacks. Am J Hypertens 1997;10 (7 Pt 1):804-12
13. Fang J, Madhavan S, Alderman MH. The association between birthplace and mortality from cardiovascular causes among black and white residents of New York City. N Engl J Med 1996;335(21):1545-51
14. Chapman JN, Mayet J, Chang CL, et al. Ethnic differences in the identification of left ventricular hypertrophy in the hypertensive patient. Am J Hypertens 1999;12(5):437-42
15. Brancati FL, Kao WH, Folsom AR, et al. Incident type 2 diabetes mellitus in African American and white adults: the Atherosclerosis Risk in Communities Study. JAMA 2000;283(17):2253-9
16. Gillum RF, Mussolino ME, Madans JH. Coronary heart disease risk factors and attributable risks in African-American women and men: NHANES I epidemiologic follow-up study. Am J Public Health 1998;88(6):913-7
17. Goldstein LB, Adams R, Becker K, et al. Primary prevention of ischemic stroke: a statement for healthcare from the Stroke Council of the American Heart Association. Circulation 2001;103(1):163-82
18. Becker LB, Han BH, Meyer PM, et al. Racial differences in the incidence of cardiac arrest and subsequent survival: the CPR Chicago Project. N Engl J Med 1993;329(9):600-6
19. Sowers JR. Diabetes mellitus and cardiovascular disease in women. Arch Intern Med 1998;158(6):617-21
20. Liao Y, Cooper RS, McGee DL, et al. The relative effects of left ventricular hypertrophy, coronary artery disease, and ventricular dysfunction on survival among black adults. JAMA 1995;273(20):1592-7
21. Klag MJ, Whelton PK, Randall BL, et al. End-stage renal disease in African-American and white men: 16-year MRFIT findings. JAMA 1997;277(16):1293-8
22. US Renal Data System. USRDS 2001 annual data report: atlas of endstage renal disease in the United States. Bethesda: National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases, 2001
23. Diez Roux AV, Merkin SS, Arnett D, et al. Neighborhood of residence and incidence of coronary heart disease. N Engl J Med 2001;345(2):99-106
24. He J, Klag MJ, Appel LJ, et al. Seven-year incidence of hypertension in a cohort of middle-aged African Americans and whites. Hypertension 1998;31(5):1130.5
25. Exner DV, Dries DL, Domanski MJ, et al. Lesser response to angiotensin-converting enzyme inhibitor therapy in black as compared with white patients with left ventricular dysfunction. N Engl J Med 2001; 344(18):1351-7
26. Yancy CW, Fowler MB, Colucci WS, et al. Race and the response to adrenergic blockade with carvedilol in patients with chronic heart failure. N Engl J Med 2001;344(18):1358-65
27. Sareli P, Radevski IV, Valtchanova ZP, et al. Efficacy of different drug classes used to initiate antihypertensive treatment in black subjects: results of a randomized trial in Johannesburg, South Africa. Arch Intern Med 2001;161(7):965-71
28. Weir MR, Gray JM, Paster RP, et al. Differing mechanisms of action of angiotensin-converting enzyme inhibition in black and white hypertensive patients. The Trandolapril Multicenter Study Group. Hypertension 1995;26(1):124-30
29. Bolen JC, Rhodes L, Powell-Griner EE, et al. State-specific prevalence of selected health behaviors, by race and ethnicity. Behavioral Risk Factor Surveillance System, 1997. Morb Mortal Wkly Rep CDC Surveill Summ 2000;49(2):1-60